Polyinosinic:polycytidylic acid (Poly I:C) and polyadenylic:polyuridylic acid (Poly A:U) are synthetic analogs of viral dsRNAs which are recognized by TLR3 (105) that have been extensively used as an adjuvant in many clinical trials for cancer vaccines (106). This evidence concerns the gene TLR3 and cancer.